USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
APPLIED GENETIC TECHNOLOGIES CORPORATION
Address:
APPLIED GENETIC TECHNOLOGIES CRP
12085 RESEARCH DR, STE 110
ALACHUA, FL 32615-0683
Phone:
(386) 462-2204
URL:
N/A
EIN:
593553710
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $531,518.00 3

Award List:

TREATMENT OF ANEMIA USING AAV VECTORS

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$256,725.00
Agency:
HHS
Principal Investigator:
Mark C. Walker
Abstract:
DESCRIPTION (applicant's abstract): The innovative use of AAV vector technology is proposed to develop milestones essential for the safe treatment of anemia secondary to chronic renal failure in cats. An A.AV-FeEPO vector has been constructed. The initial, in vitro, study… More

Molecular Breeding of Gene Therapy Vectors

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$131,711.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): We propose to develop Gene Therapy vectors that are targeted to particular cell membrane receptors, cell types and/or tissues. Development of these precise delivery systems will help overcome potential adverse reactions and high dosing requirements imposed by the… More

rAAV5-hCNGB3 Gene Therapy for Achromatopsia: Efficacy in a Dog Model

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$143,082.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Complete achromatopsia is an inherited retinal disorder characterized by severely reduced visual acuity, nystagmus, severe photophobia, a small central scotoma, eccentric fixation, and complete loss of color discrimina tion. In 50% of patients with achromatopsia… More